Secondary Burkitt lymphoma in a retinoblastoma patient with 13q deletion syndrome

Pediatric Blood and Cancer

Volumn 46, Issue 4, 2006, Pages 524-526

  Hongeng, Suradej ^a   Parapakpenjun, Surapan ^a   Pakakasama, Samart ^a   Rerkamnuaychoke, Busaba ^a   Pornkul, Ratanaporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

13q deletion; Burkitt lymphoma; Retinoblastoma; Secondary malignancy

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CANCER REGRESSION; CASE REPORT; CHROMOSOME 13Q DELETION SYNDROME; CHROMOSOME ARM; CHROMOSOME DELETION; CLINICAL FEATURE; DISEASE ASSOCIATION; FACE DYSMORPHIA; HUMAN; INFANT; MALE; PRIORITY JOURNAL; RETINOBLASTOMA; SECOND CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; REMISSION INDUCTION; RETINOBLASTOMA; SYNDROME; TREATMENT OUTCOME;

EID: 33644677387     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20372     Document Type: Article

References (14)

1. Shields CL, Shields JA. Genetics of retinoblastoma In: Tasman WS, Jaeger E, editors. Duane's foundations of clinical ophthalmology. 3rd edition. Philadelphia, PA: Lippincot Williams and Wilkins; 2002.
2. Allderdice PW, Davis JG, Miller OJ, et al. The 13q deletion syndrome. Am J Hum Genet 1969;21:499-512.
3. Knudson AG Jr., Meadows AT, Nicholas WW, et al. Chromosomal deletion and retinoblastom. N Engl J Med 1976;295:1120-1123.
4. Turleau C, DeGroucgy J, Chavin-Colin F, et al. Cytogenetic forms of retinoblastoma: Their incidence in a survey of 66 patients. Cancer Genet Cytogenet 1985;16:321-334.
5. Lavanchy L, Munier FL, Cousin P, et al. Molecular characterization of the deletion in retinoblastoma patients with 13q14 cytogenetic anomalies. Ophthalmic Genet 2001;22:11-18.
6. Abramson DH, Ronner HJ, Ellsworth RM. Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol 1979;87:624-627.
7. Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement - with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. Clin Oncol 1991;9:123-132.
8. Moll AC, Imhof SM, Bouter LM, et al. Secondary primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet 1997;18:27-34.
9. Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 2001;108:1868-1876.
10. Hon C, Chan GC, Ha SY, et al. Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome. Ann Hematol 2004;83:481-483.
11. Feig SA. Second malignant neoplasms after successful treatment of childhood cancers. Blood Cells Mol Dis 2001;27:662-666.
12. Berger R, Le Coniat M, Derre J, et al. Secondary nonrandom chromosomal abnormalities of band 13q34 in Burkitt lymphoma-leukemia. Genes Chromosomes Cancer 1989;1:115-118.
13. Barin C, Valtat C, Briault S, et al. Structural rearrangements of chromosome 13 as additional abnormalities in Burkitt lymphoma and type 3 acute lymphoblastic leukemia. Cancer Genet Cytogenet 1992;60:206-209.
14. Lai JL, Daudignon A, Kerckaert JP, et al. Translocation (3;13)(q27;q14): A nonrandom and probably secondary structural change in non-Hodgkin lymphomas. Cancer Genet Cytogenet 1998;103:140-143.